TAT-RasGAP_317-326 kills cells by targeting inner-leaflet-enriched phospholipids

Area of Science:

• Biochemistry
• Cell Biology
• Molecular Medicine

Background:

• TAT-RasGAP_317-326 is a cell-penetrating peptide with known anticancer and antimicrobial properties.
• Its precise mechanism of cell death induction, distinct from programmed pathways, remained unelucidated.

Purpose of the Study:

• To elucidate the mode of action by which TAT-RasGAP_317-326 induces cell death.
• To investigate the role of specific phospholipids and membrane integrity in the peptide's cytotoxic effects.

Main Methods:

• Investigated peptide interaction with artificial membranes containing phosphatidylinositol-bisphosphate (PIP₂) and phosphatidylserine (PS).
• Assessed cellular resistance and sensitivity to the peptide based on PIP₂ levels and membrane repair capabilities.
• Analyzed the membrane binding, permeabilization, and translocation properties of a W317A point mutant.

Main Results:

• TAT-RasGAP_317-326 binds and disrupts artificial membranes enriched in PIP₂ and PS.
• Cellular resistance to the peptide is reduced by decreasing PIP₂ levels and increased by enhancing membrane repair.
• The W317A mutant shows impaired membrane interaction and translocation, correlating with reduced killing activity.

Conclusions:

• Cell death induced by TAT-RasGAP_317-326 is a form of necrosis resulting from physical plasma membrane disruption.
• The peptide's cytotoxicity relies on targeting specific phospholipids (PIP₂, PS) on the cytosolic side of the plasma membrane.